Clinical Trial

Today, major breakthroughs in research and development has influenced the clinical trial industry to a greater extent. Moreover, the fact that cost involved in conducting clinical trials in developing nations is less has also helped the sector grow. In addition, strict regulations in different countries, sudden rise in chronic diseases and with number of patients nearing their expiry data has played a vital role in enabling the prominent vendors stay competitive. Big Market Research reports weigh up on the major drivers, obstacles and opportunities influencing the market growth. Furthermore, the qualitative and quantitative research methodology used to examine the market share and size adds value to the overall statistics of these report. Besides analyzing the business performance across different regions, these researches conduct SWOT analysis of prominent vendors. SWOT outlines the key strengths, weaknesses, opportunities and threats faced by key market players.

No of Reports 1

India IVF Services Market by Gender (Female, Male, and Both [Combined]), Procedure (ICSI IVF, Non-ICSI IVF, and IUI), Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor Egg IVF Cycles), End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and Offering (IVF Drugs, IVF Reagents & Media, and IVF & IUI Services) - Opportunity Analysis and Industry Forecast, 2017-2023

The India IVF services market was estimated $256 million in 2016 and is anticipated to reach $ 829.5 million by 2023 growing with a CAGR of 18.2% during the market forecast period of 2017 to 2023. The India IVF services market will experience significant growth due to increase in awareness among the population with respect to infertility and programs that are projected to develop patient confid...

  • Publish Date: May 2, 2017
  • $1950